# International Society of Sports Nutrition position stand: effects of dietary antioxidants on exercise and sports performance

**Authors:** Drew E. Gonzalez, Broderick L. Dickerson, Brandon M. Roberts, Jennifer A. Kurtz, Hunter S. Waldman, Adam M. Gonzalez, Matthew J. McAllister, Jeffery L. Heileson, Richard J. Bloomer, Shawn M. Arent, Darren G. Candow, Jeffrey R. Stout, Karen A. Hecht, Bill Campbell, Chad M. Kerksick, Douglas Kalman, Jose Antonio, Richard B. Kreider

PMC · DOI: 10.1080/15502783.2026.2629828 · Journal of the International Society of Sports Nutrition · 2026-02-17

## TL;DR

This paper summarizes the International Society of Sports Nutrition's official stance on how dietary antioxidants affect exercise performance and recovery, emphasizing a balanced and individualized approach.

## Contribution

The paper provides a comprehensive, evidence-based position on the use of dietary antioxidants in sports, highlighting optimal strategies for performance and recovery.

## Key findings

- Dietary antioxidants can aid recovery but may hinder training adaptations at high doses.
- Whole foods are preferred over isolated supplements for antioxidant intake.
- Creatine, omega-3s, tart cherry, and astaxanthin show strong evidence for antioxidant benefits.

## Abstract

Following a comprehensive review, the International Society of Sports Nutrition (ISSN) has developed an official position on the role of dietary antioxidants in exercise and sport. Antioxidants play a complex, context-dependent role in vivo; they can facilitate recovery from exercise but may also hinder training adaptations when consumed at supraphysiological doses. While endogenous antioxidant systems can effectively maintain redox balance, dietary sources, particularly whole foods, can help mitigate excessive oxidative stress following intense/heavy training or inadequate recovery. The influence of dietary antioxidants depend on timing, dosage, type, and individual factors. The ISSN’s official position encompasses the following: (1) Redox balance exists on a spectrum, with mild oxidative eustress driving beneficial physiological adaptations and excessive oxidative distress impairing health, recovery, and performance; (2) Moderate levels of exercise-induced reactive oxygen and nitrogen species (ROS/RNS) can support training adaptations but excessive levels can result in muscle damage, inflammation, and reduced physical performance and immune function; (3) Endogenous and exogenous antioxidants protect cells by neutralizing free radicals and reducing oxidative damage to biomolecules; (4) FDA labeling for “antioxidant” claims applies to nutrients with established RDIs and demonstrated antioxidant activity; this typically includes vitamins C and E, β-carotene (a source of vitamin A), selenium, zinc, copper, and manganese; (5) While dietary antioxidants show potential for both direct and indirect effects, the evidence varies, and their use should be tailored to individual performance or recovery goals; (6) Long-term exercise augments endogenous antioxidant defense and should be the primary strategy for enhancing redox capacity before considering supplementation; (7) Whole foods and beverages rich in flavonoids, polyphenols, carotenoids, vitamins, and minerals are preferred antioxidant sources; (8) Dietary supplementation is best reserved for nutrient insufficiencies or deficiencies, inadequate dietary intake, or periods of high training distress; (9) Responses to supplementation vary by individual factors, such as training status, baseline antioxidant capacity, demographics, diet, and injury risk, with some antioxidant compounds offering cognitive, behavioral, or physical-related benefits; and (10) Creatine monohydrate (i.e. 0.1 g/kg/day), omega-3 fatty acids (1000–6000 mg/day EPA+DHA for 6–12 weeks), tart cherry (480 mg powder or 60–90 mL juice/day for 7–14 days), and astaxanthin (4–12 mg/day for 4–12 weeks) rank among the top nutrients for their antioxidant effects, with moderate- to high-quality evidence supporting their use in recovery or performance without interfering with training adaptations. Most others show weak or low efficacy. This position promotes an individualized, evidence-based approach, recognizing that small to moderate exercise-induced oxidative stress aids adaptation, while excess oxidative stress causes harm; it also emphasizes food-forward and dietary supplementation strategies.

## Linked entities

- **Chemicals:** vitamin C (PubChem CID 54670067), vitamin E (PubChem CID 14985), β-carotene (PubChem CID 573), selenium (PubChem CID 6326970), zinc (PubChem CID 23994), copper (PubChem CID 23978), manganese (PubChem CID 23930), EPA (PubChem CID 446284), DHA (PubChem CID 15608515), astaxanthin (PubChem CID 5281224)

## Full-text entities

- **Genes:** NOX4 (NADPH oxidase 4) [NCBI Gene 50507] {aka KOX, KOX-1, RENOX}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CYBB (cytochrome b-245 beta chain) [NCBI Gene 1536] {aka AMCBX2, CGD, CGDX, GP91-1, GP91-PHOX, GP91PHOX}, UBE3B (ubiquitin protein ligase E3B) [NCBI Gene 89910] {aka BPIDS, KOS}, NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TRIM63 (tripartite motif containing 63) [NCBI Gene 84676] {aka CMH31, IRF, MURF1, MURF2, RNF28, SMRZ}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, SELENOP (selenoprotein P) [NCBI Gene 6414] {aka SELP, SEPP, SEPP1, SeP}, SELENOS (selenoprotein S) [NCBI Gene 55829] {aka AD-015, ADO15, SBBI8, SELS, SEPS1, VIMP}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NOX1 (NADPH oxidase 1) [NCBI Gene 27035] {aka GP91-2, MOX1, NOH-1, NOH-1L, NOH1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, CAT (catalase) [NCBI Gene 847], GPX3 (glutathione peroxidase 3) [NCBI Gene 2878] {aka GPx-P, GSHPx-3, GSHPx-P}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, PLA2G4A (phospholipase A2 group IVA) [NCBI Gene 5321] {aka GURDP, PLA2G4, cPLA2, cPLA2-alpha}, PLA2G6 (phospholipase A2 group VI) [NCBI Gene 8398] {aka CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2, NBIA2A}, GPX1 (glutathione peroxidase 1) [NCBI Gene 2876] {aka GPXD, GSHPX1}, IFNA17 (interferon alpha 17) [NCBI Gene 3451] {aka IFN-alphaI, IFNA, INFA, LEIF2C1}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}
- **Diseases:** disease (MESH:D004194), neurodegenerative disease and disorders (MESH:D019636), injuries (MESH:D014947), muscle damage (MESH:D009133), inflammation (MESH:D007249), cardiometabolic disease (MESH:D024821), osteoarthritic pain (MESH:D010146), head injury (MESH:D006259), muscle (MESH:D019042), mitochondrial damage (MESH:D028361), Alzheimer's disease (MESH:D000544), diabetes (MESH:D003920), TBI (MESH:D000070642), age-related macular degeneration (MESH:D008268), glutathione deficiencies (MESH:C536835), obese (MESH:D009765), myocardial damage (MESH:D009202), fatigue (MESH:D005221), overweight (MESH:D050177), osteoarthritis (MESH:D010003), post-traumatic stress disorder (MESH:D013313), burn (MESH:D002056), overtraining syndrome (MESH:D000095027), frailty (MESH:D000073496), cramps (MESH:D009120), hypertension (MESH:D006973), deaths (MESH:D003643), LZX deficiency (MESH:C562567), colorectal cancer (MESH:D015179), cardiovascular disease (MESH:D002318), infections (MESH:D007239), impaired immune function (MESH:D007154), hypertrophy (MESH:D006984), gastrointestinal issues (MESH:D005767), bone stiffness (MESH:D001847), weight loss (MESH:D015431), concussions (MESH:D001924), food allergies (MESH:D005512), cataracts (MESH:D002386), depression (MESH:D003866), muscular (MESH:D009135), DOMS (MESH:D063806), liver injury (MESH:D017093), EIOS (MESH:D000092202)
- **Chemicals:** fat (MESH:D005223), keto acids (MESH:D007651), pyrroloquinoline quinone (MESH:D045542), metal (MESH:D008670), EGCG (MESH:C045651), theaflavin (MESH:C056068), singlet oxygen (MESH:D026082), withanolides (MESH:D054358), isothiocyanate (MESH:C037152), zeaxanthin (MESH:D065146), glycine propionyl-L-carnitine (MESH:C000588486), nitrate (MESH:D009566), Oxygen (MESH:D010100), Zinc (MESH:D015032), lactate (MESH:D019344), fucoidan (MESH:C007789), ALA (MESH:D008063), Omega-3 fatty acids (MESH:D015525), choline (MESH:D002794), cortisol (MESH:D006854), uric acid (MESH:D014527), nitrogen (MESH:D009584), Quercetin (MESH:D011794), Vit E (MESH:D014810), SFN (MESH:C016766), triglyceride (MESH:D014280), hypochlorous acid (MESH:D006997), flavonols (MESH:D044948), C (MESH:D002244), lipid hydroperoxide (MESH:D008054), CoQ10 (MESH:C024989), withaferin A (MESH:C009684), curcuminoids (MESH:D036381), EPA (MESH:D015118), advanced glycation end products (MESH:D017127), phospholipid (MESH:D010743), H2O (MESH:D014867), free radical (MESH:D005609), carotenoid (MESH:D002338), sodium nitrate (MESH:C031618), testosterone (MESH:D013739), iron (MESH:D007501), phenolic acids (MESH:C017616), arachidonic acid (MESH:D016718), acetylcholine (MESH:D000109), catechin (MESH:D002392), delphinidin-3-rutinoside (MESH:C010705), PGE2 (MESH:D015232), vitamin A (MESH:D014801), isoprostane (MESH:D028421), procyanidin (MESH:C017674), 3,5,4'-trihydroxystilbene (MESH:D000077185), alkaloids (MESH:D000470), L-citrulline (MESH:D002956), Vit C (MESH:D001205), copper (MESH:D003300), glutamate (MESH:D018698), Fucoxanthin (MESH:C025164), Xanthine (MESH:D019820), flavonol (MESH:C041477)
- **Species:** Limnospira platensis (species) [taxon 118562], Beta vulgaris (beet, species) [taxon 161934], Spinacia oleracea (spinach, species) [taxon 3562], Brassica oleracea var. viridis (collards, varietas) [taxon 3713], Withania somnifera (ashwagandha, species) [taxon 126910], Theobroma cacao (cacao, species) [taxon 3641], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Spirulina (suborder) [taxon 551299], Arachis hypogaea (goober, species) [taxon 3818], Zingiber officinale (ginger, species) [taxon 94328], Prunus cerasus (sour cherry, species) [taxon 140311], Homo sapiens (human, species) [taxon 9606], Curcuma longa (turmeric, species) [taxon 136217], Brassica oleracea var. italica (asparagus broccoli, varietas) [taxon 36774], Phaeodactylum tricornutum (species) [taxon 2850], PX clade (clade) [taxon 569578], Pinus pinaster (cluster pine, species) [taxon 71647], Allium cepa (onion, species) [taxon 4679], Punica granatum (granado, species) [taxon 22663]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915426/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12915426/full.md

## References

592 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915426/full.md

---
Source: https://tomesphere.com/paper/PMC12915426